<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-vaccines-07-00168">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shigayeva</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rudnick</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Green</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Demczuk</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Gold</surname>
    <given-names>W.L.</given-names>
   </name>
   <name>
    <surname>Johnstone</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kitai</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Krajden</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lovinsky</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Toronto Invasive Bacterial Diseases Network. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs</article-title>
  <source>Clin. Infect. Dis.</source>
  <year>2016</year>
  <volume>62</volume>
  <fpage>139</fpage>
  <lpage>147</lpage>
  <pub-id pub-id-type="doi">10.1093/cid/civ803</pub-id>
  <pub-id pub-id-type="pmid">26354970</pub-id>
 </element-citation>
</ref>
